Caroline Roan

Part of Pfizer Inc., The Pfizer Foundation, Inc. is a company committed to transparency and disclosure of activities of public interest. The company is based in New York, NY. Pfizer is dedicated to discovering breakthrough treatments, including medicines and vaccines, to benefit patients worldwide. The company is focused on treating 225 million people with these breakthrough treatments by 2025. The company's areas of interest include funding for educational activities, health education, and scientific research. Additionally, Pfizer is exploring the potential of mRNA technology to fight viruses and is working to understand the differences between biologics and biosimilars, particularly in terms of cost.

Part of Pfizer Inc., The Pfizer Foundation, Inc. is a company committed to transparency and disclosure of activities of public interest. The company is based in New York, NY. Pfizer is dedicated to discovering breakthrough treatments, including medicines and vaccines, to benefit patients worldwide. The company is focused on treating 225 million people with these breakthrough treatments by 2025. The company's areas of interest include funding for educational activities, health education, and scientific research. Additionally, Pfizer is exploring the potential of mRNA technology to fight viruses and is working to understand the differences between biologics and biosimilars, particularly in terms of cost.

Part of Pfizer Inc., The Pfizer Foundation, Inc. is a company committed to transparency and disclosure of activities of public interest. The company is based in New York, NY. Pfizer is dedicated to discovering breakthrough treatments, including medicines and vaccines, to benefit patients worldwide. The company is focused on treating 225 million people with these breakthrough treatments by 2025. The company's areas of interest include funding for educational activities, health education, and scientific research. Additionally, Pfizer is exploring the potential of mRNA technology to fight viruses and is working to understand the differences between biologics and biosimilars, particularly in terms of cost.

Part of Pfizer Inc., The Pfizer Foundation, Inc. is a company committed to transparency and disclosure of activities of public interest. The company is based in New York, NY. Pfizer is dedicated to discovering breakthrough treatments, including medicines and vaccines, to benefit patients worldwide. The company is focused on treating 225 million people with these breakthrough treatments by 2025. The company's areas of interest include funding for educational activities, health education, and scientific research. Additionally, Pfizer is exploring the potential of mRNA technology to fight viruses and is working to understand the differences between biologics and biosimilars, particularly in terms of cost.